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Abstract
Background: Despite the multitude of health challenges faced by adults living with HIV, we know of no HIV-
specific instrument developed for the purpose of describing the health-related consequences of HIV, a concept
known as disability. In a previous phase of research, adults living with HIV conceptualized disability as symptoms/
impairments, difficulties carrying out day-to-day activities, challenges to social inclusion, and uncertainty that may
fluctuate on a daily basis and over the course of living with HIV. In this paper, we describe the extent to which
existing HIV-specific health-status instruments capture the experience of disability for adults living with HIV.
Methods: We searched databases from 1980 to 2006 for English language, HIV-specific, self-reported
questionnaires consisting of at least two items that were tested for reliability and validity. We then conducted a
content analysis to assess how well existing questionnaires describe disability as defined by the Episodic Disability
Framework, a framework that conceptualizes this experience from the perspective of adults living with HIV. We
matched items of the instruments with categories of the framework to evaluate the extent to which the
instruments capture major dimensions of disability in the framework.
Results: We reviewed 4274 abstracts, of which 30 instruments met the inclusion criteria and were retrieved. Of the
four major dimensions of disability, symptoms/impairments were included in all 30 instruments, difficulties with
day-to-day activities in 16, challenges to social inclusion in 16, and uncertainty in 9. Seven instruments contained at
least 1 item from all 4 dimensions of disability (breadth) however, the comprehensiveness with which the
dimensions were represented (depth) varied among the instruments.
Conclusions: In general, symptoms/impairments and difficulties carrying out day-to-day activities were the
disability dimensions characterized in greatest depth while uncertainty and challenges to social inclusion were less
well represented. Although none of the instruments described the full breadth and depth of disability as
conceptualized by the Episodic Disability Framework, they provide a foundation from which to build a measure of
disability for adults living with HIV.
Background
With longer survival, HIV-positive individuals are facing
an increasing variety of health-related consequences and
symptoms related to HIV infection, associated treat-
ment, and concurrent health conditions [1-11].
Together, these experiences may be conceptualized as
disability. We developed a conceptual framework of dis-
ability from the perspective of adults living with HIV. In
the Episodic Disability Framework, adults living with
HIV defined disability as symptoms/impairments, diffi-
culties carrying out day-to-day activities, challenges to
social inclusion, and uncertainty that may fluctuate on a
daily basis and over the entire course living with HIV
[12,13].
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related disability mandates the development of a mea-
surement instrument. A patient-reported disability ques-
tionnaire might assess the impact of disability for both
clinical care and societal level decision making. To date,
we know of no instrument developed for the purpose of
describing HIV-specific disability. Related instruments,
such as functional status and quality of life measures,
capture some aspects of disability but may not be com-
prehensive when considering the range of health-related
consequences of HIV [14-19]. Generic disability instru-
ments may not capture population-specific disability
experiences [20-23]. The purpose of this research was to
evaluate the extent to which HIV-specific health status
instruments capture disability experienced by adults liv-
ing with HIV using the Episodic Disability Framework.
Methods
The Episodic Disability Framework
In a prior phase of research, we developed a conceptual
framework of disability from the perspective of adults
living with HIV. Specifically, we conducted four focus
groups and 15 face-to-face interviews with 38 adults liv-
ing with HIV, asking individuals to describe their
health-related challenges, the physical, social and psy-
chological areas of their life affected, and the impact of
these challenges on their overall health. The resulting
Episodic Disability Framework conceptualizes disability
as multi-dimensional and episodic in nature. The frame-
work is comprised of three main components: 1) dimen-
sions of disability, 2) contextual factors that may
exacerbate or alleviate disability, and 3) triggers or life
events that may initiate a major or momentous episode
for adults living with HIV. Details of this framework
were previously published [12,13].
Instruments: Search Strategy and Inclusion Criteria
To identify measures related to disability, we systemati-
cally searched the health and psychology literature for
instruments that capture elements of the disability
experience for adults living with HIV (Figure 1). We
searched the following databases for articles published
between 1980 and March 2006: MEDLINE, CINAHL,
HAPI, EMBASE, and PsycINFO. Subject headings
included exploded terms for HIV, HIV infections, health
status indicators, quality of life, disability evaluation,
behaviour and behaviour mechanisms, activities of daily
living, psychiatric status rating scales, data collection,
work, socioeconomic factors, signs and symptoms, men-
tal disorders, uncertainty, culture, family, social environ-
ment, social isolation, socialization, sociometric
techniques, religion, spiritual therapies, and stigma.
Slight modifications of this strategy were made for each
database. We reviewed abstracts yielded from the search
for instruments relevant to disability. If it was unclear
from the abstract whether an instrument was applicable,
we pulled the full article for review. We also searched
reference lists from pertinent articles for potentially rele-
vant instruments.
We included instruments that were published in Eng-
lish, were HIV-specific self-reported questionnaires
including at least two items, and had been tested for
reliability and validity. We excluded instruments that
measured constructs un-related to the four dimensions
of disability in the Episodic Disability Framework. When
we were uncertain whether to include an instrument or
if the instrument was not published within the article,
we requested further information from study authors.
Analysis
We analyzed instruments using content analysis, a quali-
tative method in which pre-defined categories of text are
matched against each other and used to compare docu-
ments [24]. We compared each instrument against the
Episodic Disability Framework [12] We evaluated the
instruments against the dimensions of disability in the
framework [12] (Figure 2). These dimensions were clas-
sified into 10 high-level categories and 72 detailed sub-
categories. For example, an item about fatigue received
ah i g h - l e v e lc a t e g o r yo f“symptom/impairment” and a
sub-category of “fatigue/decreased energy level.” We cre-
ated new sub-categories for instrument items that did
not match a pre-identified classification. These new sub-
categories represented contextual factors or triggers of
disability or items beyond the scope of the framework.
See Additional File 1 for a detailed overview of
categories.
One author categorized all instruments. To assess
validity, we assessed agreement between this categoriza-
tion and that of a community-based author who cate-
gorized eight randomly selected instruments. We
calculated percent agreement for each instrument by
dividing the number of items categorized identically by
the total number of items in the instrument. We deter-
mined percent agreement for detailed sub-categories,
high-level categories, and dimensions of disability. The
two raters reconciled any differences by consensus.
We mapped items from the instruments onto a matrix
according to the category that they represented within the
disability framework. An instrument with greater repre-
sentation of the dimensions of disability in this matrix was
determined a priori to possess a greater ability to describe
the construct of disability for adults living with HIV. We
classified an instrument as having breadth if it contained
at least one item from each of the four disability dimen-
sions. We classified an instrument as having depth (for
each dimension) if it contained items which corresponded
to all pre-specified categories in a given dimension.
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We reviewed 4274 abstracts, of which 34 instruments
met the inclusion criteria. Instruments were excluded
b e c a u s et h e yw e r eu n - r e l a t e dt ot h eEpisodic Disability
Framework, were measures of adherence to medications,
attitudes towards death, internal locus of control, atti-
tudes towards health providers, quality of care, satisfac-
tion, utility indices, disclosure, knowledge about HIV/
AIDS, sexual and risk behaviour. Of the 34 instruments
identified for inclusion, 30 were retrieved (Table 1). We
were unable to retrieve four instruments after three
attempts to contact the authors [25-28].
Description of Instruments
The included instruments were developed between 1989
and 2006, 19 of which were published after 1996 when
triple drug combination antiretroviral therapy started to
be used widely. The number of items in the instruments
ranged from nine in the Impact of Weight Loss Scale to
177 in the HIV Overview of Problems-Evaluation Sys-
tem (HOPES). Instruments measured nine different con-
structs as identified by authors, the majority of which
included health-related quality of life/quality of life
(HRQL/QOL) (n = 14 instruments), followed by symp-
toms (n = 7), body image (n = 2), stress (n = 2), fatigue
Figure 1 Overview of Content Analysis Methodology: An overview of the content analysis methodology including the search strategy,
abstract review, document analysis of included instruments, validity check, and mapping of items from the instruments according to the
category (or code) they represented in the Episodic Disability Framework.
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cal adjustment (n = 1), and impact of weight loss
(n = 1) (Table 1).
Document Analysis
There were 108 possible categories to which an item
could be assigned for the document analysis, 72 of
which represented categories within the four dimensions
of disability within the Episodic Disability Framework
(Figure 2). An additional 36 categories were generated;
15 of which represented contextual factors (n = 12) and
triggers (n = 3) of disability within the framework and
21 that went beyond the scope of the Episodic Disability
Framework (see Additional File 1 for a detailed overview
of categories).
Our validity check demonstrated that agreement for
the sub-set of eight instruments varied depending on
the level to which the items were categorized. At the
most detailed category level (108 possible categories),
agreement ranged from 52% in the HIV Quality of Life
Questionnaire (HIV-QL31) to 79% in the Functional
Assessment of HIV Infection (FAHI) Questionnaire. At
the high-level categorization (10 possible categories),
agreement ranged from 61% in the HIV-QL31 to 85% in
the FAHI Questionnaire. At the dimension of disability
level (4 possible categories), we achieved 100% agree-
ment for all eight instruments.
Breadth and Depth of Disability in Instruments
Of the four major dimensions in the Episodic Disability
Framework, symptoms/impairments were included in all
30 instruments, difficulties with day-to-day activities in
16, challenges to social inclusion in 16, and uncertainty
in 9 (Table 2). Seven instruments demonstrated breadth,
that is, they measured some part of all 4 dimensions of
disability [29-35]. The number of items in these instru-
ments ranged from 29 (HIV/AIDS Stress Scale) to 177
(HOPES). Authors classified six of the seven scales as
HRQL/QOL instruments [29-34], and the other, a stress
scale [35] (Table 1).
No instrument captured all of the dimensions of dis-
ability comprehensively. The depth in which the dimen-
sions of disability were represented varied among the
instruments (Table 2). We highlight eight instruments
that most comprehensively represented each of the 4
dimensions of disability.
Figure 2 Episodic Disability Framework: The four dimensions of disability in the Episodic Disability Framework and the number of categories
that represent each dimension used for the content analysis.
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toms/impairments representing 25 categories, eight of
which related to stress, anxiety and depression and emo-
tional challenges. The Revised Sign and Symptom
Checklist (SSC-HIVrev) captured 27 categories, of which
two addressed stress, anxiety and depression, and emo-
tional challenges. Alternatively, the World Health
Organization’s Quality of Life HIV Instrument (WHO-
QOL-HIV) and Living with HIV Scale were the most
comprehensive at capturing symptoms/impairments that
specifically related to stress, anxiety and depression, and
emotional challenges with seven and eight categories,
respectively, but possessed fewer categories that repre-
sented physical symptoms/impairments (4 categories in







Body Image Scale [41] Martinez et al Body Image 2005 12
Assessment of Body Change and Diarrhea Scale
(ACBD) [42]
Guaraldi et al Body Image 2006 27
HIV Diarrhea Questionnaire [43] Mertz et al Diarrhea 1995 14
HIV-Related Fatigue Scale [44] Barroso & Lynn Fatigue 2000 56
Health-Related Quality of Life Scale (HIV-QOL) [18] Cleary et al HRQL/QOL 1993 46
AIDS Health Assessment Questionnaire
(AIDS-HAQ) [45]
Lubeck & Fries HRQL/QOL 1994 55
Functional Assessment of HIV Infection (FAHI) [29,46] Cella & Peterman HRQL/QOL 1997 47
HIV Overview of Problems-Evaluation System
(HOPES) [30,47]
Ganz & Schag HRQL/QOL 1992 177
HIV/AIDS Targeted QOL (HAT-QOL) [31,48] Holmes & Shea HRQL/QOL 1999 35
HIV Patient Assessed Report of Status and Experience
(HIV-PARSE) [49]
Bozzette et al HRQL/QOL 1989 144
HIV QOL Questionnaire (HIV-QL31) [32] Leplege et al HRQL/QOL 1997 31
Medical Outcomes Survey HIV Health Survey (MOS-
HIV) [50,51]
Wu et al HRQL/QOL 1997 35
Multidimensional QOL Questionnaire for HIV/AIDS
(MQoL-HIV) [33]
Avis et al HRQL/QOL 1994 40
World Health Organization QOL HIV Instrument
(WHOQOL-HIV) [34,52,53]
Fang, O’Connell & WHO HIV/AIDS Quality
of Life Group
HRQL/QOL 2002 120
General Health Self Assessment [54] Lenderking et al HRQL/QOL 1997 50
Living with HIV Scale[55] Holzemer et al HRQL/QOL 1998 32
HIV Cost and Services Utilization Tool [56] Hays et al HRQL/QOL 1998 31
AIDS Clinical Trials Group (ACTG Outcomes SF-21) [57] AIDS Clinical Trials Group Outcomes
Committee
HRQL/QOL 1999 21
Existential Loneliness Questionnaire [58] Mayers et al Loneliness 2002 22
Mental Adjustment to HIV Scale (MAHIVS) [59] Ross et al Psychological
Adjustment
1994 40
HIV/AIDS Stress Scale [35] Pakenham & Rinaldis Stress 2002 29
HIV Stressor Scale [60] Thompson et al Stress 1996 25
Physical Symptoms of Illness Scale [27] Nokes et al Symptoms 1994 15
HIV Symptom Index (Justice) [61] Justice et al Symptoms 1998 20
Sign and Symptom Checklist for HIV (SSC-HIV) [62] Holzemer et al Symptoms 1999 26
Riverside Symptom Checklist [63] Burgess et al Symptoms 1993 28
Revised Sign and Symptom Checklist for HIV
(SSC-HIVrev) [64]
Holzemer et al Symptoms 2001 72
HIV Symptom Index (Whalen) [65] Whalen Symptoms 1994 12
Self-Report Slowness Scale (SRSS) [66] Lopez et al Symptoms 1998 11
Impact of Weight Loss Scale [67] Wagner & Rabkin Weight Loss 1999 9
^Construct measured as defined by the author.
HRQL = health-related quality of life; QOL = quality of life
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Body Image Scale 5 No No
Assessment of Body Change and
Diarrhea Scale (ACBD)
9 1 No No
HIV Diarrhea Questionnaire 2 No No
HIV-Related Fatigue Scale 4 10 2 No No
Health-Related Quality of Life
Scale (HIV-QOL)
18 8 No No
AIDS Health Assessment
Questionnaire (AIDS-HAQ)
2 12 No Yes
Functional Assessment of HIV
Infection (FAHI)
12 1 4 1 Yes Yes
HIV Overview of Problems-
Evaluation System (HOPES)
25 10 4 1 Yes Yes
HIV/AIDS Targeted QOL (HAT-
QOL)
7 1 2 2 Yes Yes
HIV Patient Assessed Report of
Status and Experience (HIV-
PARSE)
21 12 3 No Yes
HIV QOL Questionnaire (HIV-QL-
31)
9 6 1 1 Yes No
Medical Outcomes Survey HIV
Health Survey (MOS-HIV)




8 8 1 1 Yes No
World Health Organization QOL
HIV Instrument (WHOQOL-HIV)
11 6 3 1 Yes Yes
General Health Self Assessment 16 7 2 No No
Living with HIV Scale 9 No Yes
HIV Cost and Services Utilization
Tool
4 10 2 No No
AIDS Clinical Trials Group (ACTG
Outcomes SF-31)
56 2 N o N o
Existential Loneliness
Questionnaire
4 1 No No
Mental Adjustment to HIV Scale
(MAHIVS)
4 1 No No
HIV/AIDS Stress Scale 8 5 3 1 Yes No
HIV Stressor Scale 1 2 No No
Physical Symptoms of Illness
Scale
12 No No
HIV Symptom Index (Justice) 18 No No
Sign and Symptom Checklist for
HIV (SSC-HIV)
13 No No
Riverside Symptom Checklist 18 No No
Revised Sign and Symptom
Checklist for HIV (SSC-HIVrev)
27 No Yes
HIV Symptom Index (Whalen) 12 No No
Self-Report Slowness Scale (SRSS) 1 9 No No
Impact of Weight Loss Scale 3 2 No No
Number of categories of disability represented for each dimension within existing HIV-specific instruments (in alphabetical order based on construct measured).
Breadth of disability is defined as an instrument having at least 1 item (or category) represented in each of the four disability dimensions. Depth of disability is
defined as having all possible categories represented in a given dimension.
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HIV Scale).
For difficulties with day-to-day activities, the AIDS
Health Assessment Questionnaire (AIDS-HAQ) and
HIV Patient Assessed Report of Status and Experience
(HIV-PARSE) each captured the most depth in this
dimension (Table 2). Items captured a range of daily
activities, some of which included walking, stair negotia-
tion, activities of daily living, and household chores, all
of which were sub-categories in the Episodic Disability
Framework.
The FAHI and the HOPES represented all categories
of challenges to social inclusion. The most common ele-
ment of social inclusion missing from the other instru-
ments that represented this dimension related to items
that captured the challenges related to fulfilling parental
roles (Table 2).
Uncertainty was less well represented by the instru-
ments. The HIV/AIDS Targeted Quality of Life Scale
(HAT-QOL) was the most comprehensive capturing
both categories from this dimension. The remaining
eight instruments (out of nine) that represented the
dimension of uncertainty all captured one category com-
p r i s e do fi t e m st h a ta d d r e s s e dw o r r y i n ga b o u tt h e
future, but did not address the impact uncertainty has
on making life decisions (Table 2).
Five of the eight comprehensive instruments were
developed from 1996 onwards (Table 1). These instru-
ments frequently captured challenges to social inclusion
and uncertainty. Four instruments (FAHI, HOPES, HAT-
QOL and WHOQOL-HIV) demonstrated both breadth
and depth. The HOPES was the only instrument that
demonstrated depth in more than one dimension (symp-
toms/impairments and challenges to social inclusion).
Discussion
No existing HIV-specific health instrument fully cap-
tured both the breadth and depth of disability as con-
ceptualized from the perspective of adults living with
HIV in the Episodic Disability Framework. Several possi-
ble reasons explain this finding. First, these instruments
were not developed to measure disability. Accordingly,
we did not expect these instruments to fully capture the
breadth and depth of disability. Second, disability is a
new and emerging construct in the context of HIV.
Recent development of the Episodic Disability Frame-
work identified features of disability that were not con-
sidered a component of disablement in earlier generic
disability frameworks, which explains why uncertainty
was less represented among these older measures.
Third, many instruments were developed prior to the
advent of combination antiretroviral therapy and may
not address associated new complexities relating to
adverse effects, stigma and disclosure, access issues, and
uncertainty about long term outcomes of treatment.
Fourth, many of the quality of life instruments we stu-
died were modified from existing generic instruments
(e.g. MOS-HIV) or disease-specific instruments in other
contexts such as cancer (e.g. HOPES). Such instruments
might not capture disablement unique to adults living
with HIV, such as issues related to returning to work.
Fifth, a greater number of items did not always translate
into a greater ability for an instrument to capture dis-
ability. For example, while two instruments appeared to
possess breadth or depth at capturing dimensions of dis-
ability, they were lengthy comprised of more than 140
items (HIV-PARSE and HOPES scale). They demon-
strated redundancy within a given category raising ques-
tions about feasibility for use of these measures in a
clinical setting. Altogether, it is not surprising that exist-
ing instruments do not fully address the spectrum of
disability for adults living with HIV. Nevertheless, ana-
lyses of these questionnaires may serve as a foundation
from which to build a disability instrument.
A measure of disability that corresponds to dimen-
sions of the Episodic Disability Framework could be
developed by pooling items from existing instruments
into a new one for adults living with HIV. For example,
most items from existing instruments represented symp-
toms/impairments from the framework. This was not
surprising given 16 of the 30 instruments were devel-
oped for the purpose of either measuring a combination
of symptoms (n = 7) or a specific symptom/impairment
(n = 9). Difficulties with day-to-day activities also were
well captured by the instruments, commonly repre-
sented in instruments originally developed to measure
symptoms/impairments and HRQL/QOL. The depth in
which these two dimensions were represented provide a
comprehensive group of existing items from which to
pool together and formulate domains of symptoms/
impairments and difficulties with day-to-day activities of
a future disability measure.
Challenges to social inclusion and uncertainty were
less well represented in the instruments. Since the intro-
duction of combination antiretroviral therapy, there has
been a shift to consider the broader health-related con-
sequences that adults living with HIV might experience
and specifically disability is becoming increasingly
important to consider in the context of HIV [36]. Issues
related to labour force and income support and worry-
ing about the unpredictable and episodic nature of HIV
are examples of types of disability faced by adults living
longer with HIV. Accordingly, newer instruments
appeared to more closely capture these two disability
dimensions in the Episodic Disability Framework and
may be a source from which to draw existing items for
a new measure. Nevertheless, generation of new items
will likely be required to fully capture these dimensions.
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a new HIV-specific disability questionnaire. For each of
the disability dimensions we may identify instruments
that most comprehensively cover a dimension with the
least amount of item redundancy. Items from the next
most comprehensive instruments may be used to fill any
remaining gaps in existing categories. Categories not
represented by any existing items would require item
generation and could be done in consultation with adults
living with HIV. This process may yield a collection of
items that comprehensively represent each of the four
disability dimensions that could be combined to com-
prise a new measure of HIV-disability. Once developed,
measurement properties of this questionnaire including
sensibility, validity, reliability and responsiveness could
be assessed with adults living with HIV.
Our study has limitations. We excluded generic
instruments or instruments developed for use with
other illness populations in order to focus on describing
disability specifically from the experience of adults living
with HIV. We also excluded questionnaires that
addressed other components of the Episodic Disability
Framework (contextual factors and triggers of disability).
However, these instruments may possess content that
relates to the dimensions of disability experienced by
adults living with HIV. We only cross-validated eight
instruments in the document analysis from which low
levels of agreement at the sub-category level were initi-
ally attained. This was likely due to the large number of
categories that an item could be assigned. New ques-
tionnaires also have been published since March 2006
and are not captured in this analysis. We performed an
updated search from 2006-July 2010 for new HIV-speci-
fic health status instruments. Results yielded four instru-
ments that appeared to meet our inclusion criteria
[37-40]. Three instruments were HRQL/QOL measures;
the Missoula-Vitas Quality-of-Life Index developed to
assess quality of life in advanced HIV illness in a pallia-
tive care setting [37], the Neurological Quality of Life
Questionnaire, a general measure of quality of life in
HIV infection [38], and the Chronic Illness Quality of
Life Ladder developed to assess quality of life across
four time periods (past, present, future, and life without
a diagnosis of HIV) [39]. The fourth instrument was a
lipodystrophy scale developed to assess the severity of
lipodystrophy from the perspective of individuals living
with HIV [40]. Similar to the instruments included in
our study, none of these instruments were developed to
assess the construct of disability. Also, none contained
items that represent the dimension of uncertainty.
Conclusions
No existing HIV-specific instrument fully captures the
breadth and depth of disability experienced by adults
living with HIV as conceptualized by the Episodic Dis-
ability Framework. Symptoms/impairments and difficul-
ties carrying out day-to-day activities were characterized
in greatest depth among most instruments, whereas
challenges to social inclusion and uncertainty were less
well represented. Nevertheless, these instruments may
serve as a foundation from which to build a future
instrument of disability. Future steps include using the
Episodic Disability Framework as a foundation from
which to establish a collection of items that will formu-
late a new instrument to describe disability experienced
by adults living with HIV. Development of a new HIV
disability questionnaire is currently underway.
Additional material
Additional file 1: Detailed Overview of Categories and Sub-
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